PIM
RXDX
Platinum Investment Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-231,521
| Closed | -$24.8M | – | 161 |
|
|
2023
Q1 | $24.8M | Sell |
231,521
-34,270
| -13% | -$3.68M | 0.86% | 27 |
|
|
2022
Q4 | $29.2M | Sell |
265,791
-87,565
| -25% | -$9.63M | 1.11% | 21 |
|
|
2022
Q3 | $20.9M | Sell |
353,356
-78,211
| -18% | -$4.62M | 0.87% | 27 |
|
|
2022
Q2 | $12.2M | Hold |
431,567
| – | – | 0.46% | 35 |
|
|
2022
Q1 | $16.3M | Sell |
431,567
-89,962
| -17% | -$3.4M | 0.5% | 34 |
|
|
2021
Q4 | $20.6M | Buy |
521,529
+19,009
| +4% | +$752K | 0.57% | 34 |
|
|
2021
Q3 | $11.9M | Buy |
502,520
+147,619
| +42% | +$3.5M | 0.34% | 42 |
|
|
2021
Q2 | $8.72M | Buy |
354,901
+213,753
| +151% | +$5.25M | 0.2% | 48 |
|
|
2021
Q1 | $2.58M | Buy |
+141,148
| New | +$2.58M | 0.06% | 78 |
|